| Literature DB >> 30081619 |
Somayeh Momenyan1, Amir Kavousi2, Jalal Poorolajal3, Narges Momenyan4.
Abstract
OBJECTIVES: Understanding the geographic variation of HIV/AIDS mortality risk and human immunodeficiency virus (HIV) infection could help identify high-burden areas. The aim of our study was to evaluate the effects of predictors of the time interval between HIV diagnosis to death, while accounting for spatial correlations across counties, and to assess patterns of spatial inequalities in the risk of HIV/AIDS mortality in Hamadan Province, Iran.Entities:
Keywords: HIV/AIDS; Iran; Mortality; Spatial correlation; Survival analysis
Mesh:
Year: 2018 PMID: 30081619 PMCID: PMC6232660 DOI: 10.4178/epih.e2018038
Source DB: PubMed Journal: Epidemiol Health ISSN: 2092-7193
Predictor factors of the patients by their final outcome in a cohort study in Hamadan, Iran (1997-2011)
| Variable | Alive or lost to follow-up (n=403) | AIDS or non-AIDS-related death (n=182) | Total (n) | p-value |
|---|---|---|---|---|
| Sex | <0.001 | |||
| Male | 344 (66.0) | 177 (34.0) | 521 | |
| Female | 59 (92.2) | 5 (7.8) | 64 | |
| Marital status | 0.13 | |||
| Single | 194 (72.4) | 74 (27.6) | 268 | |
| Married | 149 (66.8) | 74 (33.2) | 223 | |
| Divorced | 45 (60.0) | 30 (40.0) | 75 | |
| Widow | 15 (78.9) | 4 (21.1) | 19 | |
| Age (yr) | 0.01 | |||
| 1-24 | 54 (76.1) | 17 (23.9) | 71 | |
| 25-44 | 319 (69.8) | 138 (30.2) | 457 | |
| 45-74 | 30 (52.6) | 27 (47.4) | 57 | |
| Tuberculosis infection | <0.001 | |||
| No | 396 (70.2) | 168 (29.8) | 564 | |
| Yes | 7 (33.3) | 14 (66.7) | 21 | |
| Mode of HIV transmission[ | 0.001 | |||
| Injection drug use | 310 (65.3) | 165 (34.7) | 475 | |
| Sexual | 62 (86.1) | 10 (13.9) | 72 | |
| Mother to child | 8 (88.9) | 1 (11.1) | 9 | |
| Injection drug use/sexual | 21 (80.8) | 5 (19.2) | 26 |
Values are presented as number (%).
AIDS, acquired immunodeficiency syndrome; HIV, human immunodeficiency virus.
There are missing values for 3 individuals.
Results of the spatial Weibull regression model for the risk of HIV/AIDS death in a cohort study in Hamadan, Iran (1997-2011)
| Variable | Unadjusted estimate | Adjusted estimate | ||
|---|---|---|---|---|
| Mean±SD | HR (95% CI) | Mean±SD | HR (95% CI) | |
| Sex | ||||
| Male | 1.00 (reference) | 1.00 (reference) | ||
| Female | -1.56±0.48 | 0.23 (0.07, 0.48) | -1.41±0.58 | 0.28 (0.07, 0.70) |
| Marital status | ||||
| Single | 1.00 (reference) | 1.00 (reference) | ||
| Married | 0.30±0.16 | 1.37 (0.97, 1.86) | 0.35±0.17 | 1.44 (1.01, 2.00)[ |
| Divorced | 0.57±0.21 | 1.81 (1.14, 2.68)[ | 0.44±0.23 | 1.59 (0.97, 2.41) |
| Widow | -0.13±0.54 | 0.99 (0.26, 2.23) | 0.05±0.55 | 1.21 (0.31, 2.77) |
| Age (yr) | ||||
| 1-24 | 1.00 (reference) | 1.00 (reference) | ||
| 25-44 | 0.36±0.26 | 1.49 (0.89, 2.47) | 0.07±0.26 | 1.12 (0.65, 1.88) |
| 45-74 | 1.08±0.31 | 3.12 (1.62, 5.61)[ | 0.67±0.32 | 2.07 (1.04, 3.81)[ |
| Tuberculosis infection | ||||
| No | 1.00 (reference) | 1.00 (reference) | ||
| Yes | 0.71±0.28 | 2.13 (1.13, 3.46)[ | 0.67±0.29 | 2.04 (1.07, 3.37)[ |
| Mode of transmission | ||||
| Injection drug use | 1.00 (reference) | 1.00 (reference) | ||
| Sexual | -0.86±0.33 | 0.44 (0.20, 0.78) | -0.29±0.39 | 0.80 (0.32, 1.53) |
| Mother to child | -1.75±1.23 | 0.30 (0.01, 1.16) | -0.30±1.34 | 1.42 (0.03, 5.95) |
| Injection drug user/sexual | -0.52±0.47 | 0.65 (0.21, 1.35) | -0.25±0.48 | 0.86 (0.27, 1.81) |
SD, standard deviation; HR, hazard ratio; CI, credible interval.
p<0.05.
Figure 1.Maps of the HIV/AIDS death risk in a cohort study in Hamadan, Iran (1997-2011) by a spatial Weibull regression model without covariates (A) and with covariates (B).